In this regard, our results of eosinophilia regulation by the STR agonists via a preferential effect on macrophage IL‐1β production may provide an alternative therapeutic modality to alleviate ECRS, particularly prior to its progression to severe and recurrent CRSwNP. Here, IL1B is linked to chronic rhinosinusitis with nasal polyps.